7h
Fintel on MSNB of A Securities Downgrades Sutro Biopharma (STRO)Fintel reports that on March 14, 2025, B of A Securities downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) from ...
BELOW will present some of the brightest stars from Broadway, cabaret, jazz, and beyond, including Jenn Colella, and more.
Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...
In their open-label, multicentre, randomised, non-inferiority trial of home-based ovulation monitoring in the management of frozen-thawed embryo transfers (FETs), Tjitske Zaat and colleagues showed ...
The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.
BioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with ...
Major indices closed lower on Thursday as market participants digested yet another key inflation reading and new tariff ...
Explore the Cancer Vaccines Market size, share, trends, and growth forecast. Learn about key industry players, advancements, and future opportunities in oncology ...
People walk past the Nasdaq market site as U.S. stock markets opened Tuesday following Monday’s broad sell-off in New York City, U.S., March 11, 2025. REUTERS/Mike Segar/File photo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results